{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:05:28Z","timestamp":1780394728919,"version":"3.54.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015499","name":"Jeonbuk National University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015499","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.canep.2022.102245","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T14:05:24Z","timestamp":1662559524000},"page":"102245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Cancer risk associated with the use of valsartan in Korea: A nationwide cohort study"],"prefix":"10.1016","volume":"80","author":[{"given":"Ha-Lim","family":"Jeon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Hyun","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.canep.2022.102245_bib1","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes-2020","volume":"43","author":"American Diabetes Association","year":"2020","journal-title":"Diabetes care"},{"issue":"14","key":"10.1016\/j.canep.2022.102245_bib2","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1161\/CIRCULATIONAHA.109.192064","volume":"119","author":"Jessup","year":"2009","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.canep.2022.102245_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tem.2005.07.009","article-title":"Angiotensin receptors: a new role in cancer?","volume":"16","author":"Deshayes","year":"2005","journal-title":"Trends Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.canep.2022.102245_bib4","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1158\/1535-7163.MCT-09-0161","article-title":"Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor","volume":"8","author":"Soto-Pantoja","year":"2009","journal-title":"Mol. Cancer Ther."},{"issue":"4","key":"10.1016\/j.canep.2022.102245_bib5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/HJH.0b013e328344a7de","article-title":"Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals","volume":"29","author":"Trialists","year":"2011","journal-title":"J. Hypertens."},{"issue":"1","key":"10.1016\/j.canep.2022.102245_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1470-2045(10)70260-6","article-title":"Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials","volume":"12","author":"Bangalore","year":"2011","journal-title":"Lancet Oncol."},{"issue":"12","key":"10.1016\/j.canep.2022.102245_bib7","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/ajh\/hpw095","article-title":"The use of telmisartan and the incidence of cancer","volume":"29","author":"Tascilar","year":"2016","journal-title":"Am. J. Hypertens."},{"issue":"18","key":"10.1016\/j.canep.2022.102245_bib8","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003600","article-title":"Angiotensin II receptor blockers and cancer risk: a meta-analysis of randomized controlled trials","volume":"95","author":"Zhao","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.canep.2022.102245_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e2697","article-title":"Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK general practice research database","volume":"344","author":"Bhaskaran","year":"2012","journal-title":"BMJ"},{"issue":"16","key":"10.1016\/j.canep.2022.102245_bib10","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1161\/CIRCULATIONAHA.110.007336","article-title":"Use of angiotensin receptor blockers and the risk of cancer","volume":"123","author":"Pasternak","year":"2011","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.canep.2022.102245_bib11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1470-2045(10)70106-6","article-title":"Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials","volume":"11","author":"Sipahi","year":"2010","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.canep.2022.102245_bib12","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1124\/pr.112.007278","article-title":"A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists","volume":"65","author":"Michel","year":"2013","journal-title":"Pharm. Rev."},{"issue":"1","key":"10.1016\/j.canep.2022.102245_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s42444-019-0005-0","article-title":"Validation of diagnostic codes of major clinical outcomes in a national health insurance database","volume":"20","author":"Park","year":"2019","journal-title":"Int. J. Arrhythmia"},{"issue":"2","key":"10.1016\/j.canep.2022.102245_bib14","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4143\/crt.2021.044","article-title":"Validation of cancer diagnosis based on the national health insurance service database versus the national cancer registry database in Korea","volume":"54","author":"Yang","year":"2022","journal-title":"Cancer Res. Treat."},{"issue":"7","key":"10.1016\/j.canep.2022.102245_bib15","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/oem.2006.030031","article-title":"Exposure and dose modelling in occupational epidemiology","volume":"64","author":"Kriebel","year":"2007","journal-title":"Occup. Environ. Med."},{"issue":"2","key":"10.1016\/j.canep.2022.102245_bib16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5051\/jpis.2018.48.2.92","article-title":"Charlson comorbidity index as a predictor of periodontal disease in elderly participants","volume":"48","author":"Lee","year":"2018","journal-title":"J. Periodontal Implant Sci."},{"key":"10.1016\/j.canep.2022.102245_bib17","unstructured":"National Health Insurance Service, Expansion of health insurance coverage for cancer patients., 2021. \u3008https:\/\/www.nhis.or.kr\/static\/html\/wbma\/c\/wbmac0215.html\u3009. (Accessed Nov 22 2021)."},{"issue":"56","key":"10.1016\/j.canep.2022.102245_bib18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/jncimonographs\/lgaa008","article-title":"Evaluation of confounding and selection bias in epidemiological studies of populations exposed to low-dose, high-energy photon radiation","volume":"2020","author":"Schubauer-Berigan","year":"2020","journal-title":"J. Natl. Cancer Inst. Monogr."},{"issue":"3","key":"10.1016\/j.canep.2022.102245_bib19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/pds.2074","article-title":"The role of the c-statistic in variable selection for propensity score models","volume":"20","author":"Westreich","year":"2011","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"6","key":"10.1016\/j.canep.2022.102245_bib20","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/ejcts\/ezy167","article-title":"Statistical primer: propensity score matching and its alternatives","volume":"53","author":"Benedetto","year":"2018","journal-title":"Eur. J. Cardio-Thorac. Surg.: Off. J. Eur. Assoc. Cardio-Thorac. Surg."},{"issue":"21","key":"10.1016\/j.canep.2022.102245_bib21","first-page":"357","article-title":"N-nitrosodimethylamine-contaminated valsartan and the risk of cancer","volume":"118","author":"Gomm","year":"2021","journal-title":"Dtsch. Arzteblatt Int."},{"key":"10.1016\/j.canep.2022.102245_bib22","unstructured":"LiverTox, Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012\u2013. Valsartan. \u3008https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK547944\/\u3009. (Accessed Nov 17 2021)."},{"issue":"4","key":"10.1016\/j.canep.2022.102245_bib23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40471-015-0053-5","article-title":"The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application","volume":"2","author":"Lund","year":"2015","journal-title":"Curr. Epidemiol. Rep."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782122001503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782122001503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:34:11Z","timestamp":1761802451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782122001503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":23,"alternative-id":["S1877782122001503"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2022.102245","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer risk associated with the use of valsartan in Korea: A nationwide cohort study","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2022.102245","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102245"}}